LB-06

N/A

Report date: 2024/11/11 11:16:51
NMEFirst In Class

Base Information

Drug NameLB-06
Drug Alias NameLB-06
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Langrui Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Langrui Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A